How to appeal a Cigna men's sexual health — trt + ed denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for men's sexual health — trt + ed

Cited policy: Cigna PDE5 Inhibitor (Sildenafil / Tadalafil / Vardenafil / Avanafil) PA

Diagnosis of ED (ICD-10 F52.21 / N52.x). Trial of generic sildenafil at adequate dose typically required before brand or non-preferred PDE5i, unless contraindication, intolerance, or specific clinical indication (BPH/LUTS overlap → tadalafil daily, food-restriction concerns → avanafil rapid onset). Quantity limits typical (e.g., 6 tablets / 30 days for PRN, 30 / 30 for daily). Documentation of organic vs psychogenic ED workup.

How Cigna denies men's sexual health — trt + ed — and how to counter it

Where Cigna pushes back: 1) Generic sildenafil first; 2) Quantity limit exceeded; 3) ED considered cosmetic / lifestyle; 4) Try counseling first.

Counter-arguments that hold up: AUA ED 2018 (Burnett J Urol 2018) endorses ALL FOUR PDE5 inhibitors as PARALLEL first-line — clinician-patient choice based on duration of action, food effect, side-effect profile, partner-timing preferences. Tadalafil 5 mg DAILY uniquely co-treats LUTS/BPH (FDA-approved indication) — cite if IPSS / BPH coexists. Avanafil rapid onset + lower side effects justified for specific tolerability. ED is medical condition not cosmetic — AUA 2018 recognizes profound QoL + relationship impact + organic risk-factor signal. Counseling is ADJUNCT, not prerequisite (AUA 2018 algorithm). Document organic risk factors (DM, CV, post-RP, post-RT) + prior PDE5i trials at maximum dose.

What Cigna typically denies for men's sexual health — trt + ed

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For men's sexual health — trt + ed, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the men's sexual health — trt + ed treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Testosterone cypionate
• Testosterone enanthate
• Aveed (TU IM)
• Xyosted (TE SC)
• Testosterone gel
• Axiron (T solution)

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.